The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cells

Wim Kruit; Paul Schmitz; Gerrit Stoter

doi:10.1007/s002620050582

The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cells

Wim Kruit
, Paul Schmitz
, Gerrit Stoter

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	331-335
Number of pages	5
Journal	Cancer Immunology Immunotherapy
Volume	48
DOIs	https://doi.org/10.1007/s002620050582
Publication status	Published - 1999

Research programs

EMC MM-03-86-12

Access to Document

10.1007/s002620050582

http://hdl.handle.net/1765/60845

Cite this

@article{c7906a3ac6824a1bae50f4bf19ce0ad1,

title = "The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cells",

author = "Wim Kruit and Paul Schmitz and Gerrit Stoter",

year = "1999",

doi = "10.1007/s002620050582",

language = "Undefined/Unknown",

volume = "48",

pages = "331--335",

journal = "Cancer Immunology Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science+Business Media",

}

TY - JOUR

T1 - The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cells

AU - Kruit, Wim

AU - Schmitz, Paul

AU - Stoter, Gerrit

PY - 1999

Y1 - 1999

U2 - 10.1007/s002620050582

DO - 10.1007/s002620050582

M3 - Article

SN - 0340-7004

VL - 48

SP - 331

EP - 335

JO - Cancer Immunology Immunotherapy

JF - Cancer Immunology Immunotherapy

ER -